Publish in this journal
Journal Information
Vol. 65. Issue 10.
Pages 956 (October 2012)
Share
Share
Download PDF
More article options
Vol. 65. Issue 10.
Pages 956 (October 2012)
DOI: 10.1016/j.rec.2010.11.025
Full text access
Transapical Access Closure of a Mechanical Mitral Prosthesis Leak
Cierre vía transapical de leak sobre prótesis mitral mecánica
Visits
7279
Luis Fernándeza, David Rodrigoa,
Corresponding author
jdavidrodrigo@gmail.com

Corresponding author: jdavidrodrigo@gmail.com
, Pedro M. Péreza
a Laboratorio de Ecocardiografía, Hospital de Cruces, Barakaldo, Vizcaya, Spain
This item has received
7279
Visits
Article information
Full Text
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text

A 62-year-old woman with a history of rheumatic mitral valve disease and commissurotomy closed in 1969, implantation of a Shiley biological mitral prosthesis in 1978, and its replacement in 1998 by a No. 25 Bjork mechanical prosthesis, showed symptoms consistent with congestive heart disease and analytical findings indicating hemolytic anemia. Transesophageal echocardiography detected 2 mitral periprosthetic leaks, a severe one at P2 and a mild one at P3 (Figure 1).

Figure 1.

A decision was made to close the P2 leak, but because the patient had undergone 3 previous heart surgeries, a minimally invasive approach by transapical route was chosen, this being the simplest technique.

The procedure was carried out in the operating room with the patient under general anesthesia. A left minithoracotomy was performed (Figure 2) with apical access, and an Amplatzer device was implanted over the P2 defect under radioscopic and transesophageal echocardiographic guidance (Figure 3); the outcome was satisfactory.

Figure 2.

Figure 3.

At hospital discharge 5 days later, the patient was asymptomatic and laboratory analyses showed no hemolysis. At 10 days, a transesophageal echocardiographic follow-up study showed that the procedure had been effective, with only a minimal residual leak.

Periprosthetic leaks are a relatively common finding (2% to 3% of mitral prosthesis implantations). When they are severe, they tend to produce symptoms of congestive heart failure or hemolytic anemia.

Percutaneous closure is usually contemplated in patients with a history of several previous heart surgeries or multiple comorbid conditions. An anterograde (transapical) or retrograde (trans-septal) approach can be performed, with success rates of 60% to 90%.

Corresponding author: jdavidrodrigo@gmail.com

Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.